Structural integration in hypoxia-inducible factors
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The hypoxia-inducible factors (HIFs) coordinate cellular adaptations to low oxygen stress by regulating transcriptional programs in erythropoiesis, angiogenesis and metabolism. These programs promote the growth and progression of many tumours, making HIFs attractive anticancer targets. Transcriptionally active HIFs consist of HIF-α and ARNT (also called HIF-1β) subunits. Here we describe crystal structures for each of mouse HIF-2α-ARNT and HIF-1α-ARNT heterodimers in states that include bound small molecules and their hypoxia response element. A highly integrated quaternary architecture is shared by HIF-2α-ARNT and HIF-1α-ARNT, wherein ARNT spirals around the outside of each HIF-α subunit. Five distinct pockets are observed that permit small-molecule binding, including PAS domain encapsulated sites and an interfacial cavity formed through subunit heterodimerization. The DNA-reading head rotates, extends and cooperates with a distal PAS domain to bind hypoxia response elements. HIF-α mutations linked to human cancers map to sensitive sites that establish DNA binding and the stability of PAS domains and pockets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite this success, the druggable PAS-B pocket exploited by belzutifan is not conserved in HIF-1α [274], necessitating fundamentally different strategies for selective HIF-1α inhibition.”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [274]
Citations
Cites
1 retracted
RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
RetractedFeatures and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Clustal W and Clustal X version 2.0
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,358
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Deciphering key features in protein structures with the new ENDscript server
Robert, X., & Gouet, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku316 · Cited by 7,053
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Cited by
Transcriptional architecture of the mammalian circadian clock
Takahashi, J. S. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.150 · Cited by 2,635
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612
Targeting renal cell carcinoma with a HIF-2 antagonist
Chen, W., Hill, H., Christie, A., Kim, M. S., Holloman, E., Pavia-Jimenez, A., Homayoun, F., Ma, Y., Patel, N., Yell, P., et al. (2016) · Nature · doi:10.1038/nature19796 · Cited by 709
Hypoxia-inducible factors: cancer progression and clinical translation
Wicks, E. E., & Semenza, G. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159839 · Cited by 580
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
“Subsequently, the HIF-α subunit interacts with HIF-1β to form a transcriptional complex dimerization, then entering the nucleus and combining with hypoxia-responsive elements (HREs), inducing the expression of numerous downstream genes.(31,32) Notably, HIF-3α exerts an opposite role in the induction of hypoxia-related…”
BackgroundTargeting the HIF2–VEGF axis in renal cell carcinoma
Choueiri, T. K., & Kaelin, W. G. (2020) · Nature Medicine · doi:10.1038/s41591-020-1093-z · Cited by 477
Oxygen availability and metabolic adaptations
Nakazawa, M. S., Keith, B., & Simon, M. C. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.84 · Cited by 435
The ever-expanding role of HIF in tumour and stromal biology
LaGory, E. L., & Giaccia, A. J. (2016) · Nature Cell Biology · doi:10.1038/ncb3330 · Cited by 430
Singhal, R., & Shah, Y. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011188 · Cited by 376
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Wallace, E. M., Rizzi, J. P., Han, G., Wehn, P. M., Cao, Z., Du, X., Cheng, T., Czerwinski, R. M., Dixon, D. D., Goggin, B. S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0473 · Cited by 336
Mechanisms of hypoxia signalling: new implications for nephrology
Schödel, J., & Ratcliffe, P. J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0182-z · Cited by 309
Hoefflin, R., Harlander, S., Schäfer, S., Metzger, P., Kuo, F., Schönenberger, D., Adlesic, M., Peighambari, A., Seidel, P., Chen, C.-Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17873-3 · Cited by 292
Pharmacologic Targeting of Hypoxia-Inducible Factors
Semenza, G. L. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021637 · Cited by 288
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
Ivan, M., & Kaelin, W. G. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.002 · Cited by 273
“The recent discovery that the HIF1 PAS domains, like the HIF2 PAS domain, contain hydrophobic pockets should stimulate efforts to identify direct HIF1 antagonists (Wu et al., 2015).”
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Zhao, Y., Xiong, W., Li, C., Zhao, R., Lu, H., Song, S., Zhou, Y., Hu, Y., Shi, B., & Ge, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01652-9 · Cited by 249
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
Yuan, X., Ruan, W., Bobrow, B., Carmeliet, P., & Eltzschig, H. K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00848-6 · Cited by 245
“Acriflavine represents another nonspecific HIF inhibitor that desta-bilizes the HIFα–HIF1β heterodimer by directly interacting with amino acid residues Arg266 and Val305 of HIF1β 65 .”
Qiu, G.-Z., Jin, M.-Z., Dai, J.-X., Sun, W., Feng, J.-H., & Jin, W.-L. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 245
Frost, J., Galdeano, C., Soares, P., Gadd, M. S., Grzes, K. M., Ellis, L., Epemolu, O., Shimamura, S., Bantscheff, M., Grandi, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms13312 · Cited by 239
The Distinct Role of HIF-1α and HIF-2α in Hypoxia and Angiogenesis
Bakleh, M. Z., & Zen, A. A. H. (2025) · Cells · doi:10.3390/cells14090673 · Cited by 209
Hypoxia-inducible factors: a central link between inflammation and cancer
Triner, D., & Shah, Y. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84430 · Cited by 199
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
Samanta, D., & Semenza, G. L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.002 · Cited by 190
Courtney, K. D., Ma, Y., Diaz de Leon, A., Christie, A., Xie, Z., Woolford, L., Singla, N., Joyce, A., Hill, H., Madhuranthakam, A. J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1459 · Cited by 188
Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells
Marinelli, L., Martin-Gallausiaux, C., Bourhis, J.-M., Béguet-Crespel, F., Blottière, H. M., & Lapaque, N. (2019) · Scientific Reports · doi:10.1038/s41598-018-37019-2 · Cited by 181
Structural Basis for Aryl Hydrocarbon Receptor-Mediated Gene Activation
Schulte, K. W., Green, E., Wilz, A., Platten, M., & Daumke, O. (2017) · Structure · doi:10.1016/j.str.2017.05.008 · Cited by 164
Zhang, J., Yao, M., Xia, S., Zeng, F., & Liu, Q. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00682-7 · Cited by 126
Helix–loop–helix proteins and the advent of cellular diversity: 30 years of discovery
Murre, C. (2019) · Genes & Development · doi:10.1101/gad.320663.118 · Cited by 159
The crosstalk between HIFs and mitochondrial dysfunctions in cancer development
Bao, X., Zhang, J., Huang, G., Yan, J., Xu, C., Dou, Z., Sun, C., & Zhang, H. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03505-1 · Cited by 152
Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
Jin, X., Dai, L., Ma, Y., Wang, J., & Liu, Z. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01370-0 · Cited by 150
Zhou, L., Wang, Y., Zhou, M., Zhang, Y., Wang, P., Li, X., Yang, J., Wang, H., & Ding, Z. (2018) · Nature Communications · doi:10.1038/s41467-018-03914-5 · Cited by 147
The role of hypoxia‐inducible factor‐2 alpha in angiogenesis
Befani, C. D., & Liakos, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26805 · Cited by 139
Seok, S.-H., Lee, W., Jiang, L., Molugu, K., Zheng, A., Li, Y., Park, S., Bradfield, C. A., & Xing, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617035114 · Cited by 127
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
Chan, M. C., Holt‐Martyn, J. P., Schofield, C. J., & Ratcliffe, P. J. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.01.001 · Cited by 135
Kang, C. H., Lee, D. H., Lee, C. O., Du Ha, J., Park, C. H., & Hwang, J. Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.169 · Cited by 122
Cross-Species Insights Into Genomic Adaptations to Hypoxia
Pamenter, M. E., Hall, J. E., Tanabe, Y., & Simonson, T. S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00743 · Cited by 132
Structural characterization of mammalian bHLH-PAS transcription factors
Wu, D., & Rastinejad, F. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.09.011 · Cited by 122
Self-citationMechanisms of Binding Specificity among bHLH Transcription Factors
de Martin, X., Sodaei, R., & Santpere, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179150 · Cited by 113
The aryl hydrocarbon receptor: structure, signaling, physiology and pathology
Coumoul, X., Barouki, R., Esser, C., Haarmann‐Stemmann, T., Lawrence, B. P., Lehmann, J., Moura‐Alves, P., Murray, I. A., Opitz, C. A., Perdew, G. H., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02500-8 · Cited by 122
Bidirectional modulation of HIF-2 activity through chemical ligands
Wu, D., Su, X., Lu, J., Li, S., Hood, B. L., Vasile, S., Potluri, N., Diao, X., Kim, Y., Khorasanizadeh, S., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0234-5 · Cited by 111
Self-citationBahman, F., Choudhry, K., Al‐Rashed, F., Al‐Mulla, F., Sindhu, S. T. A. K., & Ahmad, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1421346 · Cited by 117
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia
Toledo, R. A., Jiménez, C., Armaiz-Peña, G., Arenillas, C., Capdevila, J., & Dahia, P. L. M. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac025 · Cited by 114
The role of HIF-1α in chemo-/radioresistant tumors
Xia, Y., Jiang, L., & Zhong, T. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s158206 · Cited by 98
Modeling the binding of diverse ligands within the Ah receptor ligand binding domain
Giani Tagliabue, S., Faber, S. C., Motta, S., Denison, M. S., & Bonati, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47138-z · Cited by 106
Hypoxia-mediated drug resistance in breast cancers
McAleese, C. E., Choudhury, C., Butcher, N. J., & Minchin, R. F. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.045 · Cited by 106
Bharathiraja, P., Yadav, P., Sajid, A., Ambudkar, S. V., & Prasad, N. R. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101004 · Cited by 103
Yan, Y., He, M., Zhao, L., Wu, H., Zhao, Y., Han, L., Wei, B., Ye, D., Lv, X., Wang, Y., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00963-8 · Cited by 101
The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer
Patel, S. A., Hirosue, S., Rodrigues, P., Vojtasova, E., Richardson, E. K., Ge, J., Syafruddin, S. E., Speed, A., Papachristou, E. K., Baker, D., et al. (2022) · Nature · doi:10.1038/s41586-022-04809-8 · Cited by 98
The role of hypoxia in intestinal inflammation
Shah, Y. M. (2016) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-016-0030-1 · Cited by 98
DOCK family proteins: key players in immune surveillance mechanisms
Kunimura, K., Uruno, T., & Fukui, Y. (2020) · International Immunology · doi:10.1093/intimm/dxz067 · Cited by 96
The quaternary architecture of RARβ–RXRα heterodimer facilitates domain–domain signal transmission
Chandra, V., Wu, D., Li, S., Potluri, N., Kim, Y., & Rastinejad, F. (2017) · Nature Communications · doi:10.1038/s41467-017-00981-y · Cited by 87
Self-citationChen, Z., Zuo, X., Cai, J., Zhang, Y., Han, G., Zhang, L., Ding, W., Wu, J., & Wang, X. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00378-2 · Cited by 95
PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma
Yoshino, H., Nohata, N., Miyamoto, K., Yonemori, M., Sakaguchi, T., Sugita, S., Itesako, T., Kofuji, S., Nakagawa, M., Dahiya, R., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1589 · Cited by 97
Yamamura, K., Uruno, T., Shiraishi, A., Tanaka, Y., Ushijima, M., Nakahara, T., Watanabe, M., Kido-Nakahara, M., Tsuge, I., Furue, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms13946 · Cited by 83
Targeting Protein–Protein Interactions in the HIF System
Wilkins, S. E., Abboud, M. I., Hancock, R. L., & Schofield, C. J. (2016) · ChemMedChem · doi:10.1002/cmdc.201600012 · Cited by 88
Structural determinants for NF-Y/DNA interaction at the CCAAT box
Nardone, V., Chaves-Sanjuán, A., & Nardini, M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.09.006 · Cited by 87
Sakurai, S., Shimizu, T., & Ohto, U. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.812974 · Cited by 72
Wu, D., Su, X., Potluri, N., Kim, Y., & Rastinejad, F. (2016) · eLife · doi:10.7554/elife.18790 · Cited by 85
Self-citationYang, H., Geng, Y., Wang, P., Zhou, Y., Yang, H., Huo, Y., Zhang, H., Li, Y., He, H., Tian, X., et al. (2019) · Cancer Science · doi:10.1111/cas.14086 · Cited by 74
Structural insight into the ligand binding mechanism of aryl hydrocarbon receptor
Dai, S., Qu, L., Li, J., Zhang, Y., Jiang, L., Wei, H., Guo, M., Chen, X., & Chen, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-33858-w · Cited by 67
Current strategies and progress for targeting the “undruggable” transcription factors
Zhuang, J., Liu, Q., Wu, D., & Tie, L. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00852-9 · Cited by 79
Self-citationUpregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer
Wang, Y.-P., Sun, N., Lü, C., Bei, Y.-B., Qian, R., & Hua, L. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3987 · Cited by 78
D’Anna, F., Dyck, L. V., Xiong, J., Zhao, H., Berrens, R. V., Qian, J., Bieniasz-Krzywiec, P., Chandra, V., Schoonjans, L., Matthews, J. B., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02087-z · Cited by 79
Self-citationSouza, R. F., Bayeh, L., Spechler, S. J., Tambar, U. K., & Bruick, R. K. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.10.004 · Cited by 78
Lan, F., Yue, X., & Xia, T. (2020) · Oncology Letters · doi:10.3892/ol.2020.11249 · Cited by 78
Hypoxia driven glycation: Mechanisms and therapeutic opportunities
Khan, M. I., Rath, S., Adhami, V. M., & Mukhtar, H. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.008 · Cited by 75
BMAL1–HIF2A heterodimer modulates circadian variations of myocardial injury
Ruan, W., Li, T., Bang, I. H., Lee, J. W., Deng, W., Ma, X., Luo, C., Du, F., Yoo, S. H., Kim, B., et al. (2025) · Nature · doi:10.1038/s41586-025-08898-z · Cited by 74
Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex
Diao, X., Shang, Q., Guo, M., Huang, Y., Zhang, M., Chen, X., Liang, Y., Sun, X., Zhou, F., Zhuang, J., et al. (2025) · Nature communications · doi:10.1038/s41467-025-56574-7 · Cited by 72
Self-citationOrchestration of Circadian Timing by Macromolecular Protein Assemblies
Partch, C. L. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.046 · Cited by 63
Mechanisms governing target search and binding dynamics of hypoxia-inducible factors
Chen, Y., Cattoglio, C., Dailey, G. M., Zhu, Q., Tjian, R., & Darzacq, X. (2022) · eLife · doi:10.7554/elife.75064 · Cited by 69
The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions
Gargaro, M., Scalisi, G., Manni, G., Mondanelli, G., Grohmann, U., & Fallarino, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020757 · Cited by 69
Li, L., Lin, Z., Yuan, J., Li, P., Wang, Q., Cho, N., Wang, Y., & Lin, Z. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116941 · Cited by 67
Li, Z., You, Q., & Zhang, X. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01596 · Cited by 65
HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies
Wang, X., Du, Z., Xu, T., Wang, X., Li, W., Gao, J.-L., Li, J., & Zhu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.785111 · Cited by 63
Spatiotemporal correlation between HIF ‐1α and bone regeneration
Tao, J., Miao, R., Liu, G., Qiu, X., Yang, B., Tan, X., Liu, L., Long, J., Tang, W. D., & Jing, W. (2022) · The FASEB Journal · doi:10.1096/fj.202200329rr · Cited by 62
Allosteric inhibition of HIF-2α as a novel therapy for clear cell renal cell carcinoma
Yu, Y.-C., Yu, Q., & Zhang, X. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.008 · Cited by 62
The circadian rhythm in intervertebral disc degeneration: an autophagy connection
Zhang, T., Li, Z., Dong, J., & Jiang, L. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0372-6 · Cited by 62
The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis
Huang, W., Rui, K., Wang, X., Peng, N., Zhou, W., Shi, X., Lu, L., Hu, D., & Tian, J. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103049 · Cited by 61
Iverson, T. M., Singh, P. K., & Cecchini, G. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104761 · Cited by 61
Cabezas‐Cruz, A., Alberdi, P., Valdés, J. J., Villar, M., & de la Fuente, J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00023 · Cited by 60
Xiang, Y., Wang, Z., Kai, J., Wang, F., Jia, Y., Wang, S., Tan, S., Shen, X., Chen, A., Shao, J., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12762 · Cited by 58
Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors
Liu, L., Yu, J., Liu, Y., Xie, L., Hu, F., & Liu, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1572909 · Cited by 56
Suyama, K., Silagi, E. S., Choi, H., Sakabe, K., Mochida, J., Shapiro, I. M., & Risbud, M. V. (2016) · Oncotarget · doi:10.18632/oncotarget.8521 · Cited by 54
Daly, L. A., Brownridge, P. J., Batie, M., Rocha, S., Sée, V., & Eyers, C. E. (2021) · Science Signaling · doi:10.1126/scisignal.abf6685 · Cited by 44
Retinoic acid receptor structures: the journey from single domains to full-length complex
Rastinejad, F. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0113 · Cited by 54
Self-citationNotch signaling, hypoxia, and cancer
Guo, M., Niu, Y., Xie, M., Liu, X., & Li, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1078768 · Cited by 53
HIF-2α phosphorylation by CK1δ promotes erythropoietin secretion in liver cancer cells under hypoxia
Pangou, E., Befani, C., Mylonis, I., Samiotaki, M., Panayotou, G., Simos, G., & Liakos, P. (2016) · Journal of Cell Science · doi:10.1242/jcs.191395 · Cited by 37
Identification of oleoylethanolamide as an endogenous ligand for HIF-3α
Diao, X., Ye, F., Zhang, M., Ren, X., Tian, X., Lu, J., Sun, X., Hou, Z., Chen, X., Li, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30338-z · Cited by 51
Self-citationYang, W., Wang, H., Wang, W.-D., Bai, P., Lu, H., Sun, C., Liu, Z., Guan, D., Yang, G., & Zhang, G. (2019) · Cancer Medicine · doi:10.1002/cam4.2642 · Cited by 51
Rao, P., & Suvas, S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800422 · Cited by 52
Hypoxia-Inducible Factor Regulates Endothelial Metabolism in Cardiovascular Disease
Ullah, K., & Wu, R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.670653 · Cited by 51
Pharmacological targeting of BMAL1 modulates circadian and immune pathways
Pu, H., Bailey, L. C., Bauer, L. G., Voronkov, M., Baxter, M. D., Huber, K., Khorasanizadeh, S., Ray, D. W., & Rastinejad, F. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01863-x · Cited by 51
Self-citationbHLH–PAS Proteins: Their Structure and Intrinsic Disorder
Kolonko, M., & Greb‐Markiewicz, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153653 · Cited by 49
Puyskens, A., Stinn, A., van der Vaart, M., Kreuchwig, A., Protze, J., Pei, G., Klemm, M., Guhlich‐Bornhof, U., HURWITZ, R. M., Gopinath, K., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.12.005 · Cited by 49
Cheng, Y., Jin, U.-H., Davidson, L. A., Chapkin, R. S., Jayaraman, A., Tamamis, P., Orr, A., Allred, C., Denison, M. S., Soshilov, A., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfw230 · Cited by 48
Coban, M., Blackburn, P. R., Whitelaw, M. L., van Haelst, M. M., Atwal, P. S., & Caulfield, T. R. (2020) · Biomolecules · doi:10.3390/biom10091314 · Cited by 48
Structural Basis for the Allosteric Inhibition of Hypoxia-Inducible Factor 2 by Belzutifan
Ren, X., Diao, X., Zhuang, J., & Wu, D. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.122.000525 · Cited by 48
Self-citationToledo, R. A. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0479 · Cited by 48
Zhou, Q., Gong, X., Kuang, G., Jiang, R., Xie, T., Tie, H., Chen, X., Li, K., Wan, J., & Wang, B. (2018) · Inflammation · doi:10.1007/s10753-018-0850-3 · Cited by 45
Zhang, T., Lv, Q., & Jin, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189137 · Cited by 44
Wu, Y., Cao, Y., Liu, H., Yao, M., Ma, N., & Zhang, B. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03776-w · Cited by 44
Ivanova, I. G., Park, C. V., & Kenneth, N. S. (2019) · Cells · doi:10.3390/cells8020114 · Cited by 44
Metadata
- Authors
- Wu, D., Potluri, N., Lu, J., Kim, Y., & Rastinejad, F.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Argonne National Laboratory (US)
- Corresponding author
- Rastinejad, Fraydoon
- Venue
- Nature
- Published
- 2015-08
- Volume
- 524
- Issue
- 7565
- Pages
- 303-308
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1929032511
- Cited by
- 346
- References
- 66
- Citations by year
- 2026: 26 · 2025: 39 · 2024: 42 · 2023: 35 · 2022: 33 · 2021: 37 · 2020: 33 · 2019: 31 · 2018: 22 · 2017: 23 · 2016: 23 · 2015: 1
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- hypoxia-inducible factor, HIF-1α, HIF-2α, ARNT, crystal structure, PAS domain, hypoxia response element, DNA binding, transcriptional regulation, low oxygen stress, anticancer drug targets
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Binding Sites, DNA, Models, Molecular, Mutation, Neoplasms, Phosphorylation, Cell Hypoxia, Protein Structure, Tertiary, Crystallography, X-Ray, Response Elements, Protein Structure, Quaternary, Mice, Aryl Hydrocarbon Receptor Nuclear Translocator, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Protein Multimerization, CLOCK Proteins, ARNTL Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.